Nature Communications

Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial

2026-01-06

Full text

DOI https://doi.org/10.1038/s41467-025-68112-6